AIM
RVMD icon

AXA Investment Managers’s Revolution Medicines RVMD Stock Holding History

AXA Investment Managers’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$4.71M Buy
+100,918
New +$3.95M 0.01% 585

Other funds holding RVMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

AXA Investment Managers's RVMD Position: Q3 2025 in Review

AXA Investment Managers opened a new position in Revolution Medicines (RVMD) in Q3 2025: 100,918 shares worth $4.71M. The stake represents 0.01% of the portfolio and ranks #585 among its holdings.

323 funds tracked by Wall St. Rank hold RVMD as of Q3 2025.

  • AXA Investment Managers held 100,918 shares of Revolution Medicines worth $4.71M as of Q3 2025.
  • Revolution Medicines was a new AXA Investment Managers position in Q3 2025.
  • Revolution Medicines made up 0.01% of AXA Investment Managers's portfolio in Q3 2025, its #585 holding.
  • 323 funds tracked by Wall St. Rank held Revolution Medicines as of Q3 2025.

Based on AXA Investment Managers's 13F filing for Q3 2025, filed 14 Nov 2025.